Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection (CHIP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Maria Grazia Revello, IRCCS Policlinico S. Matteo
ClinicalTrials.gov Identifier:
NCT00881517
First received: April 14, 2009
Last updated: December 7, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)